Charles J Homcy Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Charles J Homcy is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 916,674 shares of BBIO, which is worth approximately $45 Million. The most recent transaction as insider was on Aug 11, 2025, when has been sold 50,000 shares (Common Stock) at a price of $48.0 per share, resulting in proceeds of $2,400,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 917K

25.48% 3M change

25.48% 12M change

Total Value Held $45 Million

CHARLES J HOMCY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 11 2025	SELL Open market or private sale	$2,400,000 $48.0 p/Share	50,000 Reduced 5.17%	916,674 Common Stock
Aug 08 2025	SELL Open market or private sale	$11,562,500 $46.25 p/Share	250,000 Reduced 20.55%	966,674 Common Stock
Jun 27 2025	SELL Bona fide gift	-	20,000 Reduced 1.62%	1,216,674 Common Stock
Jun 20 2025	BUY Grant, award, or other acquisition	-	6,589 Added 0.53%	1,236,674 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$56,149 $37.21 p/Share	1,509 Reduced 0.12%	1,230,085 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	3,760 Added 0.3%	1,231,594 Common Stock
Nov 16 2023	SELL Payment of exercise price or tax liability	$37,546 $28.86 p/Share	1,301 Reduced 0.11%	1,226,996 Common Stock
Nov 16 2023	BUY Exercise of conversion of derivative security	-	3,760 Added 0.31%	1,228,297 Common Stock
Aug 16 2023	SELL Payment of exercise price or tax liability	$38,769 $29.8 p/Share	1,301 Reduced 0.11%	1,224,537 Common Stock
Aug 16 2023	BUY Exercise of conversion of derivative security	-	3,760 Added 0.31%	1,225,838 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$18,317 $14.09 p/Share	1,300 Reduced 0.11%	1,220,827 Common Stock
May 16 2023	BUY Exercise of conversion of derivative security	-	3,759 Added 0.31%	1,222,127 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$19,389 $12.64 p/Share	1,534 Reduced 0.13%	1,218,368 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	3,760 Added 0.31%	1,219,902 Common Stock
Nov 16 2022	SELL Payment of exercise price or tax liability	$12,541 $9.64 p/Share	1,301 Reduced 0.11%	1,214,251 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	-	3,760 Added 0.31%	1,215,552 Common Stock
Aug 16 2022	SELL Payment of exercise price or tax liability	$14,260 $11.08 p/Share	1,287 Reduced 0.11%	1,209,455 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	-	3,760 Added 0.31%	1,210,742 Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$10,386 $6.74 p/Share	1,541 Reduced 0.13%	1,206,982 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	-	3,759 Added 0.31%	1,208,523 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$37,681 $71.91 p/Share	524 Reduced 0.04%	1,204,764 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	1,521 Added 0.13%	1,205,288 Common Stock
Oct 16 2020	SELL Open market or private sale	$420,496 $41.0 p/Share	10,256 Reduced 0.84%	1,203,767 Common Stock
Oct 16 2020	BUY Exercise of conversion of derivative security	$174,352 $17.0 p/Share	10,256 Added 0.84%	1,214,023 Common Stock
Sep 30 2020	SELL Open market or private sale	$380,000 $38.0 p/Share	10,000 Reduced 0.82%	1,203,767 Common Stock

Also insider at

PHICW

Population Health Investment Co., Inc.

Director

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

Director

MAZE

Maze Therapeutics, Inc.

CJH

Charles J Homcy

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO

Account